Compare FSS & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FSS | GPCR |
|---|---|---|
| Founded | 1901 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 6.3B |
| IPO Year | N/A | 2023 |
| Metric | FSS | GPCR |
|---|---|---|
| Price | $120.27 | $70.41 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 12 |
| Target Price | ★ $127.33 | $103.09 |
| AVG Volume (30 Days) | 390.7K | ★ 1.0M |
| Earning Date | 02-25-2026 | 02-27-2026 |
| Dividend Yield | ★ 0.46% | N/A |
| EPS Growth | ★ 10.74 | N/A |
| EPS | ★ 3.82 | N/A |
| Revenue | ★ $2,055,400,000.00 | N/A |
| Revenue This Year | $15.50 | N/A |
| Revenue Next Year | $15.95 | N/A |
| P/E Ratio | $31.55 | ★ N/A |
| Revenue Growth | ★ 11.83 | N/A |
| 52 Week Low | $66.47 | $13.22 |
| 52 Week High | $132.89 | $94.90 |
| Indicator | FSS | GPCR |
|---|---|---|
| Relative Strength Index (RSI) | 63.69 | 42.86 |
| Support Level | $117.54 | $71.81 |
| Resistance Level | $123.68 | $81.15 |
| Average True Range (ATR) | 3.34 | 4.33 |
| MACD | 0.90 | -2.54 |
| Stochastic Oscillator | 76.40 | 5.26 |
Federal Signal Corp designs and manufactures products and integrated solutions for municipal, governmental, industrial, and airport customers. It operates in the segments of Environmental Solutions Group and the Safety and Security Systems Group. The Environmental Solutions group manufactures and supplies street sweeper vehicles, sewer cleaner and vacuum loader trucks, hydro-excavation trucks, high-performance water blasting equipment, dump truck bodies, and trailers. The Safety and Security Systems Group offers comprehensive systems and products such as campus and community alerting, emergency vehicles, first responder interoperable communications, and others. The company generates a majority of its revenue from the Environmental Solutions Group segment.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.